Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Arruda

Showing results (131-140 of 185) with videos related to

Pageof 19
Sort By:
Annals of Hematology|March 1, 1995
Molecular identification of hereditary persistence of fetal hemoglobin type 2 (HPFH type 2) in patients from BrazilM S Gonçalves, S Fahel, M S Figueiredo, et al.
The Journal of Clinical Investigation|March 2, 2021
B cell-activating factor modulates the factor VIII immune response in hemophilia ABhavya S Doshi, Jyoti Rana, Giancarlo Castaman, et al.
American Journal of Medical Genetics|August 26, 1998
Prevalence of the mutation C677 --> T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in BrazilV R Arruda, L H Siqueira, M S Gonçalves, et al.
European Journal of Haematology|August 8, 2001
Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defectsV R Arruda, C S Lima, C R Grignoli, et al.
ILAR Journal|March 19, 2009
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiencyTimothy C Nichols, Aaron M Dillow, Helen W G Franck, et al.
Blood|September 13, 2003
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1Valder R Arruda, Joerg Schuettrumpf, Roland W Herzog, et al.
Blood|September 23, 2009
Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A modelDenise E Sabatino, Christian Furlan Freguia, Raffaella Toso, et al.
Journal of Thrombosis and Haemostasis : JTH|October 8, 2014
Apoptotic effects of platelet factor VIII on megakaryopoiesis: implications for a modified human FVIII for platelet-based gene therapyT K Greene, R B Lyde, S C Bailey, et al.
Plos One|October 3, 2013
Characterization of naturally-occurring humoral immunity to AAV in sheepJoseph Tellez, Kim Van Vliet, Yu-Shan Tseng, et al.
Thrombosis and Haemostasis|July 23, 2004
Platelet glycoprotein Ibalpha polymorphisms modulate the risk for myocardial infarctionMargareth C Ozelo, Andrea F Origa, Francisco J P Aranha, et al.
Pageof 19

Showing results (131-140 of 185) with videos related to

Sort By:
Pageof 19
Annals of Hematology|March 1, 1995
Molecular identification of hereditary persistence of fetal hemoglobin type 2 (HPFH type 2) in patients from BrazilM S Gonçalves, S Fahel, M S Figueiredo, et al.
The Journal of Clinical Investigation|March 2, 2021
B cell-activating factor modulates the factor VIII immune response in hemophilia ABhavya S Doshi, Jyoti Rana, Giancarlo Castaman, et al.
American Journal of Medical Genetics|August 26, 1998
Prevalence of the mutation C677 --> T in the methylene tetrahydrofolate reductase gene among distinct ethnic groups in BrazilV R Arruda, L H Siqueira, M S Gonçalves, et al.
European Journal of Haematology|August 8, 2001
Increased risk for acute myeloid leukaemia in individuals with glutathione S-transferase mu 1 (GSTM1) and theta 1 (GSTT1) gene defectsV R Arruda, C S Lima, C R Grignoli, et al.
ILAR Journal|March 19, 2009
Protein replacement therapy and gene transfer in canine models of hemophilia A, hemophilia B, von willebrand disease, and factor VII deficiencyTimothy C Nichols, Aaron M Dillow, Helen W G Franck, et al.
Blood|September 13, 2003
Safety and efficacy of factor IX gene transfer to skeletal muscle in murine and canine hemophilia B models by adeno-associated viral vector serotype 1Valder R Arruda, Joerg Schuettrumpf, Roland W Herzog, et al.
Blood|September 23, 2009
Recombinant canine B-domain-deleted FVIII exhibits high specific activity and is safe in the canine hemophilia A modelDenise E Sabatino, Christian Furlan Freguia, Raffaella Toso, et al.
Journal of Thrombosis and Haemostasis : JTH|October 8, 2014
Apoptotic effects of platelet factor VIII on megakaryopoiesis: implications for a modified human FVIII for platelet-based gene therapyT K Greene, R B Lyde, S C Bailey, et al.
Plos One|October 3, 2013
Characterization of naturally-occurring humoral immunity to AAV in sheepJoseph Tellez, Kim Van Vliet, Yu-Shan Tseng, et al.
Thrombosis and Haemostasis|July 23, 2004
Platelet glycoprotein Ibalpha polymorphisms modulate the risk for myocardial infarctionMargareth C Ozelo, Andrea F Origa, Francisco J P Aranha, et al.
Pageof 19